Home » Briefs » State of Texas v. Merck & Co. Inc.


Econ One’s expert economists have experience across a wide variety of services including antitrust, class certification, damages, financial markets and securities, intellectual property, international arbitration, labor and employment, and valuation and financial analysis.


Econ One’s resources including blogs, cases, news, and more provide a collection of materials from Econ One’s experts.

Cases and Engagements

Get an Inside look at Economics with the experts.
Managing Director

Ph.D. in Economics, University of California, Los Angeles

M.A. in Economics, University of California, Los Angeles

B.S. in Economics, Santa Clara University

Econ One, President, 1997 – Present

Founded Econ One, 1997

Micronomics, Inc., President and CEO, 1994 – 1997

Micronomics, Inc., Executive Vice President, 1988 – 1997

Cofounded Micronomics, Inc., 1988

National Economic Research Associates, Inc. (Last position was Senior Vice President and member of the Board of Directors) 1980 – 1988

U.S. District Court

U.S. Bankruptcy Court

State Court

Federal Energy Regulatory Commission

Various state tax and regulatory commissions

Private arbitration

International Arbitration

Share this Article
September 25, 2015

State of Texas v. Merck & Co. Inc.

The State of Texas sued Merck alleging that it engaged in Medicaid fraud in connection with the marketing and sale of its withdrawn painkiller Vioxx.

Econ One was retained by the State of Texas in the case State of Texas v. Merck & Co. Inc. Econ One expert Jeffrey Leitzinger submitted an expert report regarding the total amount of reimbursements made by the State through its Medicaid Program for Vioxx. Dr. Leitzinger also provided deposition testimony. The case ultimately was dismissed with prejudice.

Services: Antitrust
Industries: Pharmaceutical

Latest Related Resources and Insights